WINT - nov 26 :
Wind-tree Is Studying Istaroxime in Early Cardiogenic Shock Patients
WARRINGTON, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the results of U.S. hospital claims...
CLSN - NOV 26:
is currently conducting the OVATION 2 clinical trial of GEN-1 in patients with advanced ovarian cancer (Stage III/IV). It is a Phase 1/2 randomized, open label, multicenter trial to evaluate the safety, efficacy, and biological activity of intraperitoneal GEN-1 plus neoadjuvant chemotherapy (NACT), compared to NACT alone. Up to 110 patients are...
AUVI - NOV 26:
Revenue increased 88.5% to $3.55 million as compared to $1.88 in the previous quarter
Gross profit increased to $1.0 million, or 29.6% vs. sales as compared to $0.5m, or 28.3% vs. sales in the previous quarter
US Index - Nov 22,
Don't bet against America, i know the charts looks hilarious, but fundamentally it will go higher and higher, until the fed increase the interest rat and then we will go from ( inflation to deflation ) and from ( Deflation to recession ).
it just my thought.